UNSPSC 51283212: Mepartricin

This classification denotes a macrolide antibiotic with the molecular formula C60H88N2O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B7FBW3Y74G, chemically known as (4E,6E,8E,10Z,12Z,14E,16E)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-23,27,29,31,33,35,37-heptahydroxy-19-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-21,25-dioxo-20,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylate but generally known as Mepartricin, which bears US NIH Compound Identifier 6479653.

UNSPSC 51283212 Mepartricin is a Commodity code that maps to pharmaceutical supply procurement, though recent state and local solicitations under this code show a broader pharmaceutical and medical-supply scope than the code name suggests. State and local governments are using this code to purchase pharmaceutical products and medical devices for public health initiatives, including antibiotics, overdose-reversal medications, and drug-disposal systems. The issuing bodies include state departments of health and county public-health agencies, which use both direct procurement and piggyback arrangements through established cooperative purchasing consortiums such as MMCAP Infuse to manage pharmaceutical supply chains. These procurement vehicles allow jurisdictions to leverage existing awards and streamlined bid processes rather than conducting independent solicitations each time.

Recent activity spans Illinois and Florida, with the Illinois Department of Public Health awarding a $2.99 million three-year piggyback contract to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through an Invitation for Bid process. Seminole County, Florida issued an IFB on June 30, 2026, for annual supplies of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems, with quarterly deliveries to its Community Health Building in Sanford; the bid deadline was July 26, 2023. Neither procurement identified set-aside or business-enterprise requirements. Vendors pursuing this code should expect to navigate cooperative purchasing agreements, pharmaceutical-licensing compliance, drug-free workplace certification, and E-Verify requirements.